Lymphoma, Hodgkin

16 registered clinical trials studyying Lymphoma, Hodgkin — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving NCT06923397	Dana-Farber Cancer Institute	N/A
Recruiting	Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignan NCT05800210	University of Florida	Phase 2
Not Yet Recruiting	Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage So NCT06363201	Catalysis SL	N/A
Completed	STAY-STRONG Study of Exercise Training During Chemotherapy NCT05556239	Rigshospitalet, Denmark	N/A
Active Not Recruiting	A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant NCT05540340	Memorial Sloan Kettering Cancer Center	Phase 1
Active Not Recruiting	Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG NCT04892667	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma NCT05410314	University of Bari Aldo Moro	—
Unknown	Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma NCT03921879	Oncotartis, Inc.	Phase 1
Terminated	Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or NCT03154710	Weprom	N/A
Unknown	Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation NCT03244930	Hospital Universitario Dr. Jose E. Gonzalez	Phase 2
Unknown	Precision Exercise in Children With Malignant Hemopathies NCT04090268	University of Milano Bicocca	N/A
Recruiting	Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III NCT03117036	Samsung Medical Center	—
Completed	Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine NCT02996773	University of Arizona	Phase 1
Completed	MELT - MRI Evaluation of Lymphoma Treatment NCT01459224	University College, London	—
Terminated	T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE NCT00578461	Baylor College of Medicine	N/A
Completed	Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgki NCT00026208	Stanford University	Phase 2